Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.

Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA, Davis PJ.

J Urol. 2002 Aug;168(2):748-55.

PMID:
12131363
2.

Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha.

Shih A, Zhang S, Cao HJ, Boswell S, Wu YH, Tang HY, Lennartz MR, Davis FB, Davis PJ, Lin HY.

Mol Cancer Ther. 2004 Nov;3(11):1355-64.

3.

Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.

Shih A, Davis FB, Lin HY, Davis PJ.

J Clin Endocrinol Metab. 2002 Mar;87(3):1223-32.

PMID:
11889192
4.

Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells.

Zhang S, Cao HJ, Davis FB, Tang HY, Davis PJ, Lin HY.

Br J Cancer. 2004 Jul 5;91(1):178-85.

5.
6.

Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells.

Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY.

Mol Cancer Ther. 2006 Aug;5(8):2034-42.

7.

Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.

Shih A, Lin HY, Davis FB, Davis PJ.

Biochemistry. 2001 Mar 6;40(9):2870-8.

PMID:
11258898
8.

Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.

Lin HY, Sun M, Tang HY, Simone TM, Wu YH, Grandis JR, Cao HJ, Davis PJ, Davis FB.

J Cell Biochem. 2008 Aug 15;104(6):2131-42. doi: 10.1002/jcb.21772.

PMID:
18446786
11.
12.

Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.

Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellón EA.

J Androl. 2007 Mar-Apr;28(2):282-93. Epub 2006 Oct 18.

13.
14.
15.

Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.

Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK.

Oncogene. 2006 Apr 6;25(15):2203-12.

PMID:
16288207
16.

Inducible COX-2-dependent apoptosis in human ovarian cancer cells.

Lin C, Crawford DR, Lin S, Hwang J, Sebuyira A, Meng R, Westfall JE, Tang HY, Lin S, Yu PY, Davis PJ, Lin HY.

Carcinogenesis. 2011 Jan;32(1):19-26. doi: 10.1093/carcin/bgq212.

17.

Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.

Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM.

Mol Nutr Food Res. 2010 Mar;54(3):335-44. doi: 10.1002/mnfr.200900143.

PMID:
20077416
18.

Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.

Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.

Mol Carcinog. 2006 Jan;45(1):26-37. Erratum in: Mol Carcinog. 2006 Jul;45(7):549. Aggarwal, Bharat A [corrected to Aggarwal, Bharat B].

PMID:
16267831
19.

Phosphorylation of mitogen-activated protein kinase is inhibited by calcitonin in DU145 prostate cancer cells.

Segawa N, Nakamura M, Nakamura Y, Mori I, Katsuoka Y, Kakudo K.

Cancer Res. 2001 Aug 15;61(16):6060-3.

Items per page

Supplemental Content

Write to the Help Desk